Kadimastem, an Israeli biopharma venture, recently declared it was hoping to discuss with the U.S. Food and Drug Administration (FDA) its AstroRX cells experimental therapy,…
The AMG Center for ALS at Mass General recently announced, along with Amylyx Pharmaceuticals, Inc., that AMX0035 demonstrated a significant treatment benefit for people with ALS…
The ALS Never Surrender Foundation, a volunteer-based, non-profit organizations on a mission to cure Motor Neuron Disease and Amyotrophic Lateral Sclerosis (ALS) announced a $300,00…
A new interdisciplinary muscle research center celebrates its opening at its central location at University of Washington (UW) Medicine South Lake Union. The Center for…
A Macquarie University investigator is leading a Phase 2/3 clinical trial that enrolled its first patient in a multi-center, randomized, double-blinded, placebo-controlled clinical trial to…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
